0001415889-22-001748.txt : 20220223
0001415889-22-001748.hdr.sgml : 20220223
20220223203453
ACCESSION NUMBER: 0001415889-22-001748
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220218
FILED AS OF DATE: 20220223
DATE AS OF CHANGE: 20220223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Watkin Jared
CENTRAL INDEX KEY: 0001645118
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 22666000
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
STREET 2: AP6A-2, D-032L
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
form4-02232022_050235.xml
X0306
4
2022-02-18
0000001800
ABBOTT LABORATORIES
ABT
0001645118
Watkin Jared
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064
false
true
false
false
SENIOR VICE PRESIDENT
Common shares without par value
2022-02-18
4
A
0
14559
0
A
74342
D
Common shares without par value
622
I
Profit Sharing Trust
Option (right to buy)
117.58
2022-02-18
4
A
0
67850
0
A
2023-02-18
2032-02-17
Common Shares
67850
67850
D
These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
Balance in the Abbott Laboratories Stock Retirement Trust as of February 18, 2022.
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 22,616 on February 18, 2023, 22,617 on February 18, 2024, and 22,617 on February 18, 2025.
/s/ Jared Watkin by Jessica H. Paik, Attorney-in-Fact
2022-02-23